- Home
- FONR vs CNTB Comparison
FONR vs CNTB Comparison
Compare FONR & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FONR
- CNTB
- Stock Information
- Founded
- FONR 1978
- CNTB 2012
- Country
- FONR United States
- CNTB United States
- Employees
- FONR N/A
- CNTB N/A
- Industry
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- FONR Health Care
- CNTB Health Care
- Exchange
- FONR Nasdaq
- CNTB Nasdaq
- Market Cap
- FONR 100.6M
- CNTB 90.3M
- IPO Year
- FONR 1987
- CNTB 2021
- Fundamental
- Price
- FONR $15.52
- CNTB $1.98
- Analyst Decision
- FONR
- CNTB Strong Buy
- Analyst Count
- FONR 0
- CNTB 2
- Target Price
- FONR N/A
- CNTB $7.50
- AVG Volume (30 Days)
- FONR 15.7K
- CNTB 96.7K
- Earning Date
- FONR 11-11-2025
- CNTB 11-13-2025
- Dividend Yield
- FONR N/A
- CNTB N/A
- EPS Growth
- FONR N/A
- CNTB N/A
- EPS
- FONR 1.26
- CNTB N/A
- Revenue
- FONR $104,351,318.00
- CNTB $1,965,000.00
- Revenue This Year
- FONR N/A
- CNTB N/A
- Revenue Next Year
- FONR N/A
- CNTB $453,067.90
- P/E Ratio
- FONR $12.48
- CNTB N/A
- Revenue Growth
- FONR 1.43
- CNTB N/A
- 52 Week Low
- FONR $12.00
- CNTB $1.23
- 52 Week High
- FONR $17.62
- CNTB $2.20
- Technical
- Relative Strength Index (RSI)
- FONR 48.92
- CNTB 61.50
- Support Level
- FONR $15.08
- CNTB $1.36
- Resistance Level
- FONR $16.25
- CNTB $1.88
- Average True Range (ATR)
- FONR 0.30
- CNTB 0.17
- MACD
- FONR 0.01
- CNTB 0.05
- Stochastic Oscillator
- FONR 34.31
- CNTB 89.02
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.